Approval · Notice of Compliance 8395 · 2006

BLEOMYCIN FOR INJECTION, USP: Notice of Compliance 8395

Issued November 8, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 8395
Date: November 8, 2006
Company: Pharmaceutical Partners Of Canada, A Division Of Abraxis Bioscience Inc.
Product type: Prescription Pharmaceutical
Submission: Abbreviated New Drug Submission (ANDS)
Submission class: Admin
Reason: Manufacturer name change
Therapeutic class: Antineoplastic / antibiotic
Canadian reference product: BLENOXANE (Bristol Laboratories Of Canada)

Products in this notice

Brand	DIN	Status today
BLEOMYCIN FOR INJECTION, USP	02265982	Marketed

Medicinal ingredients

BLEOMYCIN SULFATE 15 UNIT per VIAL